Spotlight Therapeutics

Spotlight Therapeutics is a venture-funded biotechnology company based in Hayward, California. The company employs 19 people and has generated over $10,000 in revenue. Spotlight Therapeutics is focused on developing a new class of therapeutics through direct in vivo gene editing. Their core technology platform aims to achieve precise gene editing in targeted cell populations within the body. The company's therapeutic focus centers on oncology, using engineered nucleases to edit genes in targeted disease organs, ultimately inactivating or altering the gene product. Spotlight Therapeutics is dedicated to building a cutting-edge research and development team. This team is responsible for a range of preclinical development activities, including protein engineering, gene editing, immuno-oncology, and in vivo safety studies. For more information about Spotlight Therapeutics and its work, please visit spotlighttx.com.